✦ LIBER ✦

Therapy of Advanced Prostate Cancer Part II: Response End Points and the Use of Chemotherapy

✍ Scribed by David M. Reese; Eric J. Small

Book ID: 114436339
Publisher: John Wiley and Sons
Year: 2000
Tongue: English
Weight: 174 KB
Volume: 2
Category: Article
ISSN: 1095-5100
DOI: 10.1046/j.1525-1411.2000.24001.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Can prostate-specific antigen be used as

Can prostate-specific antigen be used as a valid end point to determine the efficacy of chemotherapy for advanced prostate cancer?

✍ B. Seckin; C. T. Anthony; B. Murphy; M. S. Steiner 📂 Article 📅 1996 🏛 Springer-Verlag 🌐 English ⚖ 444 KB

It is current practice in many clinical trials evaluating new chemotherapy regimens for the treatment of advanced prostate cancer to use prostate-specific antigen (PSA) decline as a response criteria with the assumption that the level of PSA reflects the efficacy of chemotherapy. Advanced prostate c

P-glycoprotein: The intermediate end poi

P-glycoprotein: The intermediate end point of drug response to induction chemotherapy in locally advanced breast cancer

✍ Hyun Cheol Chung; Sun Young Rha; Joo Hang Kim; Jae Kyung Roh; Jin Sik Min; Kyung 📂 Article 📅 1997 🏛 Springer US 🌐 English ⚖ 50 KB

Locally Advanced Rectal Cancer: MR Imagi

Locally Advanced Rectal Cancer: MR Imaging in Prediction of Response after Preoperative Chemotherapy and Radiation Therapy 1

✍ Barbaro, Brunella; Fiorucci, Cecilia; Tebala, Carmen; Valentini, Vincenzo; Gamba 📂 Article 📅 2009 🏛 The Radiological Society of North America 🌐 English ⚖ 415 KB

Sequencing of therapy and outcomes assoc

Sequencing of therapy and outcomes associated with use of neoadjuvant chemotherapy in advanced epithelial ovarian cancer in the Medicare population

✍ M. Thrall; H. Gray; R. Symons; D. Flum; N. Weiss; B. Goff 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 51 KB

TREATMENT OF ERECTILE DYSFUNCTION FOLLOW

TREATMENT OF ERECTILE DYSFUNCTION FOLLOWING THERAPY FOR CLINICALLY LOCALIZED PROSTATE CANCER: PATIENT REPORTED USE AND OUTCOMES FROM THE SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS PROSTATE CANCER OUTCOMES STUDY

✍ STEPHENSON, ROBERT A.; MORI, MOTOMI; HSIEH, YI-CHING; BEER, TOMASZ M.; STANFORD, 📂 Article 📅 2005 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 113 KB

The role of luteinizing hormone-releasin

The role of luteinizing hormone-releasing hormone therapy in locally advanced prostate cancer and biochemical failure: considerations for optimal use

✍ Pierre Teillac; Aldo V. Bono; Jacques Irani; Manfred P. Wirth; Alexandre R. Zlot 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 758 KB